Association of the Advanced Lung Cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients with gastrointestinal and lung cancer

MLA

Hao Jiang, et al. “Association of the Advanced Lung Cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) Score with Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal and Lung Cancer.” BMC Cancer, vol. 24, no. 1, Apr. 2024, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s12885-024-12149-1.

APA

Hao Jiang, Borui Li, Min Wu, Qimei Wang, & Yijin Li. (2024). Association of the Advanced Lung Cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients with gastrointestinal and lung cancer. BMC Cancer, 24(1), 1–13. https://doi.org/10.1186/s12885-024-12149-1

Chicago

Hao Jiang, Borui Li, Min Wu, Qimei Wang, and Yijin Li. 2024. “Association of the Advanced Lung Cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) Score with Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal and Lung Cancer.” BMC Cancer 24 (1): 1–13. doi:10.1186/s12885-024-12149-1.